Login / Signup
Combination of PARP and DNA methylation inhibitors as a potential personalized therapy for SETD2-mutated clear-cell renal cancers.
Ali Shahini
Yasser Riazalhosseini
Published in:
Translational andrology and urology (2024)
Keyphrases
</>
clear cell
dna methylation
dna damage
genome wide
dna repair
gene expression
oxidative stress
young adults